Transgenic (Tg) mice overexpressing human P301L tau are known to develop robust tauopathy phenotypes and are frequently used as an AD animal model (Lewis et al., 2000; Götz et al., 2007; Banerjee et al., 2022). This evidence concerns the gene MAPT and Alzheimer disease.